Lomefloxacino [Spanish] en es it fr

Lomefloxacino [Spanish] Brand names, Lomefloxacino [Spanish] Analogs

Lomefloxacino [Spanish] Brand Names Mixture

  • No information avaliable

Lomefloxacino [Spanish] Chemical_Formula


Lomefloxacino [Spanish] RX_link


Lomefloxacino [Spanish] fda sheet

Lomefloxacino [Spanish] msds (material safety sheet)

Lomefloxacino_[Spanish] MSDS

Lomefloxacino [Spanish] Synthesis Reference

No information avaliable

Lomefloxacino [Spanish] Molecular Weight

182.172 g/mol

Lomefloxacino [Spanish] Melting Point

168 oC

Lomefloxacino [Spanish] H2O Solubility

216 mg/mL

Lomefloxacino [Spanish] State


Lomefloxacino [Spanish] LogP


Lomefloxacino [Spanish] Dosage Forms

Liquid; Powder for solution; Solution

Lomefloxacino [Spanish] Indication

Used for the promotion of diuresis before irreversible renal failure becomes established; The reduction of intracranial pressure, the treatment of cerebral edema, and the promotion of urinary excretion of toxic substances.

Lomefloxacino [Spanish] Pharmacology

Chemically, mannitol is an alcohol and a sugar, or a polyol; it is similar to xylitol or sorbitol. However, mannitol has a tendency to lose a hydrogen ion in aqueous solutions, which causes the solution to become acidic. For this reason, it is not uncommon to add a substance to adjust its pH, such as sodium bicarbonate. Mannitol is commonly used to increase urine production (diuretic). It is also used to treat or prevent medical conditions that are caused by an increase in body fluids/water (e.g., cerebral edema, glaucoma, kidney failure). Mannitol is frequently given along with other diuretics (e.g., furosemide, chlorothiazide) and/or IV fluid replacement.

Lomefloxacino [Spanish] Absorption

Approximately 7% of ingested mannitol is absorbed during gastrointestinal perfusion in uremic patients.

Lomefloxacino [Spanish] side effects and Toxicity

LD50=1700 mg/kg (rat oral)

Lomefloxacino [Spanish] Patient Information

Lomefloxacino [Spanish] Organisms Affected

Humans and other mammals